Concepedia

Indra Fernando

IF

Statistics

Publications

3

Citations

380

H-Index

3

Active since

2004

Affiliations

Joliet Oncology-Hematology Associates(Current)

Indra Fernando is an author at Joliet Oncology-Hematology Associates specializing in pharmacotherapy, medicine, and dose modification strategies.

Publications per year

2004–2009

3

Publications

3

Hematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients With Myelodysplastic Syndromes

Roger M. Lyons, Thomas M. Cosgriff, Sanjiv Modi et al. · Journal of Clinical Oncology · 2009 · 272 citations

, , +17

Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.

Joel M. Kremer, Mark C. Genovese, Grant W. Cannon et al. · PubMed · 2004 · 92 citations

, , +13

Results of the Initial Treatment Phase of a Study of Three Alternative Dosing Schedules of Azacitidine (Vidaza®) in Patients with Myelodysplastic Syndromes (MDS).

Roger M. Lyons, Thomas M. Cosgriff, Sanjiv Modi et al. · Blood · 2007 · 16 citations

, , +12

1–3 of 3